You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 12, September 25, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Review
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gastroesophageal Reflux Disease

Peter J. Kahrilas, MD

JAMA. 1996;276(12):983-988.


Abstract

Objective.
—To review the management of gastroesophageal reflux disease (GERD) in adults with esophageal complications (esophagitis, stricture, adenocarcinoma, or Barrett metaplasia) or extraesophageal complications (otolaryngological manifestations and asthma).

Data Sources.
—Peer-reviewed publications located via MEDLINE or crosscitation.

Study Selection.
—Emphasis was placed on new developments in diagnosis and therapeutics. Thus, fewer than 10% of identified citations are discussed.

Data Extraction.
—Controlled therapeutic trials were emphasized. The validity of pathophysiological observations and uncontrolled trials were critiqued by the author.

Data Synthesis.
—Esophagitis is typically a chronic, recurring disorder treated with long-term antisecretory therapy, titrated to disease severity. Laparascopic antireflux surgery is an alternative strategy, but neither long-term efficacy data nor an appropriate controlled trial comparing it with proton pump inhibitor therapy exists. The main risk of esophagitis is adenocarcinoma arising from Barrett metaplasia, the incidence of which is increasing. Strong evidence suggests that both reflux-induced asthma and otolaryngological complications (subglottic stenosis, laryngitis, pharyngitis, or cancer) can occur without esophagitis. While the otolaryngological manifestations usually respond to antisecretory medications, reflux-induced asthma responds convincingly only to antireflux surgery.

Conclusions.
—Although esophagitis and GERD symptoms predictably respond to antisecretory medicines, the risk of adenocarcinoma from Barrett metaplasia dictates that if heartburn is refractory to treatment, chronic (>5 years), or accompanied by dysphagia, odynophagia, or bleeding, it should be evaluated by endoscopy. Thereafter, patients with Barrett metaplasia require surveillance endoscopy to control the cancer risk. Reflux-induced asthma remains a vexing problem in the absence of either medical therapy of proven efficacy or a reliable mechanism of prospectively identifying affected patients.



Author Affiliations

From the Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Medical School, Chicago, III.


Footnotes

Reprints: Peter J. Kahrilas, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Medical School, Passavant Pavilion, Suite 746, 303 E Superior St, Chicago, IL 60611.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease
Savarino et al.
Gut 2009;58:1185-1191.
ABSTRACT | FULL TEXT  

Radiofrequency Energy Delivery to the Lower Esophageal Sphincter (Stretta Procedure) Does Not Provide Long-term Symptom Control
Dundon et al.
SURG INNOV 2008;15:297-301.
ABSTRACT  

Gastroesophageal Reflux Disease: Integrating the Barium Esophagram before and after Antireflux Surgery
Baker et al.
Radiology 2007;243:329-339.
ABSTRACT | FULL TEXT  

Role of Gastroesophageal Reflux Symptoms in Exacerbations of COPD.
Rascon-Aguilar et al.
Chest 2006;130:1096-1101.
ABSTRACT | FULL TEXT  

Effect of Acid and pepsin on glottic wound healing: a simulated reflux model.
Roh and Yoon
Arch Otolaryngol Head Neck Surg 2006;132:995-1000.
ABSTRACT | FULL TEXT  

Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough"
Patterson et al.
Eur Respir J 2004;24:724-727.
ABSTRACT | FULL TEXT  

Whither surgery in the treatment of gastroesophageal reflux disease (GERD)?
Urbach et al.
CMAJ 2004;170:219-221.
FULL TEXT  

Atypical manifestations of gastro-oesophageal reflux
Issing and Karkos
JRSM 2003;96:477-480.
FULL TEXT  

Laparoscopic Adjustable Gastric Banding in the Treatment of Morbid Obesity
O'Brien and Dixon
Arch Surg 2003;138:376-382.
FULL TEXT  

A 59-Year-Old Woman With Gastroesophageal Reflux Disease and Barrett Esophagus
Spechler
JAMA 2003;289:466-475.
FULL TEXT  

Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease: Follow-up of a Randomized Controlled Trial
Spechler et al.
JAMA 2001;285:2331-2338.
ABSTRACT | FULL TEXT  

Increased Prevalence of Gastroesophageal Reflux Symptoms in Patients With COPD
Mokhlesi et al.
Chest 2001;119:1043-1048.
ABSTRACT | FULL TEXT  

Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review
Coughlan et al.
Thorax 2001;56:198-204.
ABSTRACT | FULL TEXT  

Management of gastro-oesophageal reflux disease in general practice
Dent et al.
BMJ 2001;322:344-347.
FULL TEXT  

The Impact of Nocturnal Symptoms Associated With Gastroesophageal Reflux Disease on Health-Related Quality of Life
Farup et al.
Arch Intern Med 2001;161:45-52.
ABSTRACT | FULL TEXT  

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study
Lagergren et al.
Gut 2000;47:26-29.
ABSTRACT | FULL TEXT  

Effectiveness and Costs of Omeprazole vs Ranitidine for Treatment of Symptomatic Gastroesophageal Reflux Disease in Primary Care Clinics in West Virginia
Kaplan-Machlis et al.
Arch Fam Med 2000;9:624-630.
ABSTRACT | FULL TEXT  

Efficacy of Omeprazole for the Treatment of Symptomatic Acid Reflux Disease Without Esophagitis
Richter et al.
Arch Intern Med 2000;160:1810-1816.
ABSTRACT | FULL TEXT  

Acid/Pepsin Promotion of Carcinogenesis in the Hamster Cheek Pouch
Adams et al.
Arch Otolaryngol Head Neck Surg 2000;126:405-409.
ABSTRACT | FULL TEXT  

Mucosal Morbidity in Patients With Epidermolysis Bullosa Acquisita
Luke et al.
Arch Dermatol 1999;135:954-959.
ABSTRACT | FULL TEXT  

Treatment of gastro-oesophageal reflux disease in adults
Chassany et al.
BMJ 1999;318:59-59.
FULL TEXT  

Heartburn Requiring Frequent Antacid Use May Indicate Significant Illness
Robinson et al.
Arch Intern Med 1998;158:2373-2376.
ABSTRACT | FULL TEXT  

Evidence based case reports
Perry et al.
BMJ 1998;317:1386b-1386.
FULL TEXT  

Fortnightly review: Treatment of gastro-oesophageal reflux disease in adults
Galmiche et al.
BMJ 1998;316:1720-1723.
FULL TEXT  

Effects of HCl-pepsin laryngeal instillations on upper airway patency-maintaining mechanisms
Sant'Ambrogio et al.
J. Appl. Physiol. 1998;84:1299-1304.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.